Genome Research in African American Scleroderma Patients (GRASP Study)

The goal of the GRASP Study (Genome Research in African American Scleroderma Patients is to better understand how African American patients are affected by scleroderma. The Yale Scleroderma Program has partnered with Johns Hopkins University and the National Human Genome Research Institute to collect clinical data and blood samples from African American patients diagnosed with scleroderma to achieve this goal.